GlassScriptPhysician profile
Thuan H Vo
NPI 1366434748
$11,357.27
in general payments reported to CMS, 2019-2025
33 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,646 · 2020: $1,520 · 2021: $2,363 · 2022: $1,676 · 2023: $1,513 · 2024: $1,502 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,152.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,775.06 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,177.47 | 2019-2025 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $1,131.56 | 2019-2024 | Trelegy Ellipta |
| Ironwood Pharmaceuticals, INC | $785.78 | 2019-2025 | Linzess |
| Amarin Pharma, INC. | $613.40 | 2019-2023 | |
| Hikma Pharmaceuticals USA | $562.55 | 2019-2021 | |
| Amgen INC. | $534.53 | 2019-2024 | Prolia, Evenity |
| Astellas Pharma US INC | $516.48 | 2019-2023 | Veozah, Myrbetriq |
| Nestle Healthcare Nutrition INC. | $447.10 | 2020-2023 | |
| Lilly USA, LLC | $416.48 | 2019-2025 | Jardiance, Trulicity, Mounjaro |
| Abbvie INC. | $381.29 | 2019-2025 | Creon, Linzess, Viberzi |
| Pfizer INC. | $235.71 | 2019-2022 | |
| Allergan, INC. | $214.68 | 2019 | |
| Merck Sharp & Dohme LLC | $175.17 | 2020-2024 | Capvaxive, Gardasil 9, Gardasil |
| Sunovion Pharmaceuticals INC. | $173.76 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $146.10 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $132.09 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $120.78 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $114.81 | 2019 | |
| Esperion Therapeutics, INC. | $105.22 | 2021-2024 | Nexletol |
| Gilead Sciences, INC. | $101.08 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.59 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $81.53 | 2021 | |
| Novo Nordisk INC | $66.54 | 2020-2024 | Rybelsus |
| Sanofi Pasteur INC. | $47.30 | 2019-2023 | |
| Aimmune Therapeutics, INC. | $44.71 | 2024 | |
| Eyevance Pharmaceuticals LLC | $31.37 | 2021 | |
| Sumitomo Pharma America, INC. | $27.54 | 2024 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $21.40 | 2024 | Gvoke Hypopen |
| Exact Sciences Corporation | $21.23 | 2024 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $19.27 | 2019 | |
| Genentech USA, INC. | $18.98 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thuan Vo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.